Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €205.10 | €204.50 | -0.293% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Exact Sciences | 11 | 0 | 1 | 0 | €58.60 | €83.49 | 42.483% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.76 | €26.01 | 19.515% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €16.45 | €28.17 | 71.232% |
| Faes Farma S.A. | 1 | 0 | 1 | 0 | €3.29 | €6.00 | 82.371% |
| Fresenius Medical Care AG & Co KGaA ADR | 3 | 1 | 1 | 0 | €18.60 | €21.00 | 12.903% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €40.15 | €48.50 | 20.797% |
| Fresenius SE & Co. KGaA | 4 | 1 | 2 | 0 | €27.67 | - | - |
| G1 Therapeutics | 13 | 1 | 2 | 0 | €3.91 | €10.05 | 157.136% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.34 | €61.56 | 18005.618% |
| Geron Corp. | 11 | 0 | 2 | 0 | €3.27 | €4.59 | 40.585% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €102.10 | €110.00 | 7.738% |
| Glycomimetics Inc. | 5 | 0 | 1 | 0 | €1.71 | €7.35 | 328.915% |
| GSK plc | 1 | 0 | 0 | 0 | €19.20 | - | - |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.60 | €35.00 | -9.326% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €77.50 | €97.90 | 26.325% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.40 | €54.21 | 48.928% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €298.60 | €295.60 | -1.006% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €76.00 | €79.00 | 3.947% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €22.80 | €29.29 | 28.477% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.05 | - | - |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €67.98 | €79.30 | 16.653% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.61 | €4.58 | 75.230% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €72.00 | €84.03 | 16.711% |